M&A Deal Summary

Societal CDMO Acquires IRISYS

On August 13, 2021, Societal CDMO acquired life science company IRISYS for 50M USD

Acquisition Highlights
  • This is Societal CDMO’s 1st transaction in the Life Science sector.
  • This is Societal CDMO’s largest (disclosed) transaction.
  • This is Societal CDMO’s 1st transaction in the United States.
  • This is Societal CDMO’s 1st transaction in California.

M&A Deal Summary

Date 2021-08-13
Target IRISYS
Sector Life Science
Buyer(s) Societal CDMO
Deal Type Add-on Acquisition
Deal Value 50M USD
Advisor(s) Bailey Southwell & Co. (Financial)

Target

IRISYS

San Diego, California, United States
IRISYS is a full service CDMO with capabilities that range from formulation development to commercial manufacturing for various dosage forms including oral liquids, sterile injectables, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes and nano/microparticles. The company serves a diverse, global client base within the biopharmaceutical industry with its nearly 40 clients located in six different countries around the world. This includes manufacturing support for four commercial and near-commercial products. Importantly, IRISYS recently added automated, aseptic fill/finish and lyophilization capabilities to its existing facility, offering a new key avenue for significant near-term growth. IRISYS is based in San Diego, California.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Societal CDMO

Gainesville, Georgia, United States

Category Company
Founded 2007
Sector Life Science
Revenue 90M USD (2022)
DESCRIPTION

Societal CDMO is a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products. Societal CDMO was formed in 2007 and is based in Gainesville, Georgia.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1